Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA® (Rituximab Injection) in China October 9, 2020
Denali Therapeutics Announces Closing of Collaboration and Share Purchase Agreements with Biogen October 7, 2020
Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US October 6, 2020
Applied BioMath, LLC Announces Two-Year Strategic Partnership with Xilio Therapeutics October 5, 2020
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress October 5, 2020
TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement September 30, 2020
Orchard Therapeutics Receives EMA PRIME Designation for OTL-203 for the Treatment of MPS-I September 28, 2020